All articles by
Nu.Q Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
VolitionRx Limited, a multi-national epigenetics company, has announced that its Nu.Q Vet Cancer Test is now available in-clinic to veterinarians…
Concept Medical enrols first patient in MagicTouch system’s IDE study
Drug delivery technology provider Concept Medical has enrolled the first patient in investigational device exemption (IDE) MAGICAL-ISR study of its…
Immunovia’s next-gen pancreatic cancer test yields positive results in trial
Immunovia, a Swedish diagnostics company, said that its next-generation pancreatic cancer test has met both primary and secondary endpoints in…
GE HealthCare launches Voluson Signature 20 and 18 ultrasound systems for women
GE HealthCare has introduced the artificial intelligence (AI)-enhanced Voluson Signature 20 and 18 ultrasound systems to advance health imaging in…
Lumicell gets FDA nod for LumiSystem breast cancer visualisation system
Massachusetts-based Lumicell has received US Food and Drug Administration (FDA) approval for its breast cancer visualisation system dubbed LumiSystem. LumiSystem…
AtriCure introduces cryoSPHERE+ probe to manage post-operative pain
AtriCure, a surgical treatments and therapies developer, has introduced the cryoSPHERE+ cryoablation probe for post-operative pain management. The cryoSPHERE+ probe,…
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System
Medical robotics innovator Noah Medical today shared new field data from D. Kyle Hogarth, MD (University of Chicago Medical Center) and Amit…
HealthSignals Secures Telehealth Agreement with Premier
HealthSignals is proud to announce the attainment of a national group purchasing agreement for Telehealth with Premier, Inc. Effective 03/01/2024,…
Outset Medical and U.S. Renal Care partner to expand home haemodialysis in US
Outset Medical, a dialysis-focused medical technology company, has partnered with privately held kidney care provider U.S. Renal Care to accelerate…
FDA classifies Boston Scientific’s recall of Obsidio Embolic as most serious
The US Food and Drug Administration (FDA) has identified Boston Scientific’s recall of Obsidio Conformable Embolic (Obsidio Embolic) as Class…